- Raised $1.2M Seed Extension, Mar 2019
- Raised $2.4M Seed Extension, Mar 2018
- Raised $2M Seed round, Jan 2018
About
PlantEXT is an Israeli and Canadian company focused on developing science-based medical cannabis formulations. They leverage proprietary technology and research agreements with institutions like Israel's Agricultural Research Organization (ARO) to identify synergistic combinations of cannabinoids and terpenes for anti-inflammatory treatments. Their pipeline includes products for conditions such as Inflammatory Bowel Disease (IBD), psoriasis, atopic dermatitis, arthritis, pain, and migraines. PlantEXT is a pharmaceutical cannabis research and product development company led by R&D and product commercialization experts. The company's approach to development is based on knowledge and experience in the pharmaceutical industry, utilizing a systematic approach to medical cannabis development in tandem with the pharmaceutical Quality by Design approach (QbD).
Funding history · 3 rounds · $5.6M total
Headcount over time
Q&A
- What is PlantEXT's primary focus?
- PlantEXT is an Israeli and Canadian company focused on developing science-based medical cannabis formulations, specifically targeting inflammation-related conditions.
- What is PlantEXT's total funding to date?
- PlantEXT has raised a total of $5.6 million USD across multiple funding rounds.
- Who is the CEO of PlantEXT?
- Willy Kruh was appointed as the Chief Executive Officer of PlantEXT in October 2020.
- What was PlantEXT's most recent funding round?
- In April 2019, PlantEXT completed a Seed round, raising $1.2 million USD. Beacon Securities Limited was among the investors.
- What research collaborations does PlantEXT have?
- PlantEXT has a research agreement with Israel's Agricultural Research Organization (ARO) to identify synergistic combinations of cannabinoids and terpenes for anti-inflammatory treatments.
- What types of conditions does PlantEXT's product pipeline target?
- PlantEXT's pipeline includes products for conditions such as Inflammatory Bowel Disease (IBD), psoriasis, atopic dermatitis, arthritis, pain, and migraines.
Team · 1
Sectors & technology
Highlights
Tags
Full data — links, identifiers, deals & radar signals (jobs, patents, research, more)
External links
| Website | plantext.com/ |
|---|---|
| linkedin.com/company/17901135 | |
| facebook.com/Plantext-2334608700196085 |
Identifiers & details
| Legal name | PlantEXT Ltd. |
|---|---|
| Founded | 2015 |
| Employees (exact) | 7 |
| Offices | Toronto |
Radar intelligence
Web history (Wayback)
| Domain | plantext.com |
|---|
Certificate / subdomain footprint
| Subdomains | 3 |
|---|
Israeli Companies Registrar (רשם החברות / ICA)
| Registrar # (ח.פ.) | 515356384 |
|---|---|
| Status | פעילה |
| Corp type | ישראלית חברה פרטית |
| Incorporated | 2015-12-15 |
| Purpose | לעסוק בכל עיסוק חוקי |
| Liability | מוגבלת |
| In violation (unfiled) | yes |
| Last annual report | 2018 |
| Active charges / liens | 0 |
| Registry events | 0 |
| Registered address | שד' אלי לנדאו 50 הרצליה |